{"id":"https://openalex.org/W2160274347","doi":"https://doi.org/10.2337/dc11-1928","title":"Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets","display_name":"Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets","alternate_titles":[],"publication_year":2012,"publication_date":"2012-05-15","ids":{"openalex":"https://openalex.org/W2160274347","doi":"https://doi.org/10.2337/dc11-1928","mag":"2160274347","pmid":"https://pubmed.ncbi.nlm.nih.gov/22584132","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3379583"},"language":"en","primary_location":{"id":"doi:10.2337/dc11-1928","doi":"https://doi.org/10.2337/dc11-1928","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc11-1928","pdf_url":"https://care.diabetesjournals.org/content/diacare/35/7/1446.full.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2160274347"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://care.diabetesjournals.org/content/diacare/35/7/1446.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027649851","display_name":"J. Hans DeVries","orcid":"https://orcid.org/0000-0001-9196-9906","observed_orcids":["https://orcid.org/0000-0001-9196-9906"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J. Hans DeVries","raw_affiliation_strings":["Department of Internal Medicine, Academic Medical Centre, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Academic Medical Centre, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080463002","display_name":"Stephen Charles Bain","orcid":"https://orcid.org/0000-0001-8519-4964","observed_orcids":["https://orcid.org/0000-0001-8519-4964"]},"institutions":[{"id":"https://openalex.org/I39586589","display_name":"Swansea University","ror":"https://ror.org/053fq8t95","country_code":"GB","type":"education","lineage":["https://openalex.org/I39586589"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen C. Bain","raw_affiliation_strings":["Institute of Life Sciences, Swansea University and Abertawe Bro Morgannwg University NHS Trust, Swansea, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Life Sciences, Swansea University and Abertawe Bro Morgannwg University NHS Trust, Swansea, U.K","institution_ids":["https://openalex.org/I39586589"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020174004","display_name":"Helena W. Rodbard","orcid":"https://orcid.org/0000-0002-6187-8445","observed_orcids":["https://orcid.org/0000-0002-6187-8445"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helena W. Rodbard","raw_affiliation_strings":["Endocrine and Metabolic Associates, Rockville, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrine and Metabolic Associates, Rockville, Maryland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056074989","display_name":"Jochen Seufert","orcid":"https://orcid.org/0000-0001-5654-7310","observed_orcids":["https://orcid.org/0000-0001-5654-7310"]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jochen Seufert","raw_affiliation_strings":["Division of Endocrinology and Diabetology, University Hospital of Freiburg, Freiburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology and Diabetology, University Hospital of Freiburg, Freiburg, Germany","institution_ids":["https://openalex.org/I2801240073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071074041","display_name":"David A. D\u2019Alessio","orcid":"https://orcid.org/0000-0003-4155-4870","observed_orcids":["https://orcid.org/0000-0003-4155-4870"]},"institutions":[{"id":"https://openalex.org/I4210143084","display_name":"Cincinnati VA Medical Center","ror":"https://ror.org/045r80n66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210127612","https://openalex.org/I4210143084"]},{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David D\u2019Alessio","raw_affiliation_strings":["Division of Endocrinology, Diabetes, and Metabolism, University of Cincinnati, Cincinnati VA Medical Center, Cincinnati, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Metabolism, University of Cincinnati, Cincinnati VA Medical Center, Cincinnati, Ohio","institution_ids":["https://openalex.org/I4210143084","https://openalex.org/I63135867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112354612","display_name":"Anne Bloch Thomsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Anne B. Thomsen","raw_affiliation_strings":["Medical & Science, GLP-1 & Obesity, Novo Nordisk A/S, Soeborg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical & Science, GLP-1 & Obesity, Novo Nordisk A/S, Soeborg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113524401","display_name":"Marcin Zychma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Marcin Zychma","raw_affiliation_strings":["Medical & Science, GLP-1 & Obesity, Novo Nordisk A/S, Soeborg, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical & Science, GLP-1 & Obesity, Novo Nordisk A/S, Soeborg, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045489578","display_name":"Julio Rosenstock","orcid":"https://orcid.org/0000-0001-8324-3275","observed_orcids":["https://orcid.org/0000-0001-8324-3275"]},"institutions":[{"id":"https://openalex.org/I2800474951","display_name":"Medical City Dallas Hospital","ror":"https://ror.org/059rc1n32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800474951"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Julio Rosenstock","raw_affiliation_strings":["Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dallas Diabetes and Endocrine Center at Medical City, Dallas, Texas","institution_ids":["https://openalex.org/I2800474951"]}]},{"author_position":"last","author":{"id":null,"display_name":"on behalf of the Liraglutide-Detemir Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"on behalf of the Liraglutide-Detemir Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5045489578"],"corresponding_institution_ids":["https://openalex.org/I2800474951"],"apc_list":null,"apc_paid":null,"fwci":19.771,"has_fulltext":true,"cited_by_count":168,"citation_normalized_percentile":{"value":0.99661107,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"35","issue":"7","first_page":"1446","last_page":"1454"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9959999918937683},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.8650000095367432},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/insulin-detemir","display_name":"insulin detemir","score":0.9390000104904175},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.5379999876022339},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9120000004768372},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.8690000176429749},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8029999732971191},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7110000252723694}],"concepts":[{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.9564807415008545},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9485875368118286},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8842349052429199},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.7527827620506287},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7453598380088806},{"id":"https://openalex.org/C2909524832","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Basal insulin","level":4,"score":0.7136483192443848},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6230353713035583},{"id":"https://openalex.org/C2778024521","wikidata":"https://www.wikidata.org/wiki/Q55639806","display_name":"Basal (medicine)","level":3,"score":0.5988564491271973},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5360444188117981},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5315069556236267}],"mesh":[{"descriptor_ui":"D000069057","descriptor_name":"Insulin Detemir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":11,"locations":[{"id":"doi:10.2337/dc11-1928","doi":"https://doi.org/10.2337/dc11-1928","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc11-1928","pdf_url":"https://care.diabetesjournals.org/content/diacare/35/7/1446.full.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/669545","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/669545","pdf_url":"https://lirias.kuleuven.be/retrieve/04201e97-635c-42af-bcbb-fe3ff39645aa","source":{"id":"https://openalex.org/S4306401954","display_name":"Lirias (KU Leuven)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care, vol. 35 (7), (1446-54)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:europepmc.org:2690052","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3379583","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:22584132","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22584132","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3379583","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3379583/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"Text"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/692c7b1c-ea99-41b5-b85c-eb56f3998b8b","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/692c7b1c-ea99-41b5-b85c-eb56f3998b8b","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"DeVries, J H, Bain, S C, Rodbard, H W, Seufert, J, D'Alessio, D, Thomsen, A B, Zychma, M, Rosenstock, J & AUTHOR GROUP 2012, 'Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets', Diabetes care, vol. 35, no. 7, pp. 1446-1454. https://doi.org/10.2337/dc11-1928","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/32fc8edf-d04f-4d43-b89e-b91335891e01","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/sequential-intensification-of-metformin-treatment-in-type-2-diabetes-with-liraglutide-followed-by-randomized-addition-of-basal-insulin-prompted-by-a1c-targets(32fc8edf-d04f-4d43-b89e-b91335891e01).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes care, 35(7), 1446 - 1454. American Diabetes Association Inc.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:iris.unipa.it:10447/66807","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10447/66807","pdf_url":null,"source":{"id":"https://openalex.org/S4306401065","display_name":"Nova Science Publishers (Nova Science Publishers, Inc.)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:iris.uniroma1.it:11573/515913","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11573/515913","pdf_url":null,"source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/7ddd76ed-deb1-4b28-961e-d4484c98c66d","doi":null,"is_oa":true,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/7ddd76ed-deb1-4b28-961e-d4484c98c66d","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"DeVries, J H, Bain, S C, Rodbard, H W, Seufert, J, D'Alessio, D, Thomsen, A B, Zychma, M, Rosenstock, J, Liraglutide-Detemir Study Group & Narendran, P 2012, 'Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets', Diabetes Care, vol. 35, no. 7, pp. 1446-54. https://doi.org/10.2337/dc11-1928","raw_type":"article"},{"id":"pmh:oai:ricerca.univaq.it:11697/143073","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11697/143073","pdf_url":null,"source":{"id":"https://openalex.org/S7407055225","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 degli Studi dell Aquila","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2337/dc11-1928","doi":"https://doi.org/10.2337/dc11-1928","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc11-1928","pdf_url":"https://care.diabetesjournals.org/content/diacare/35/7/1446.full.pdf","source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306089","display_name":"American Diabetes Association","ror":"https://ror.org/04f6cgz95"},{"id":"https://openalex.org/F4320306493","display_name":"Abbott Laboratories","ror":"https://ror.org/0052svj16"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307768","display_name":"Amylin Pharmaceuticals","ror":"https://ror.org/043cec594"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320314793","display_name":"Intarcia Therapeutics","ror":"https://ror.org/00s0pgz81"},{"id":"https://openalex.org/F4320315142","display_name":"MannKind Corporation","ror":"https://ror.org/02vbfm330"},{"id":"https://openalex.org/F4320319264","display_name":"MacroGenics","ror":"https://ror.org/01hcd4187"},{"id":"https://openalex.org/F4320320065","display_name":"Diabetes UK","ror":"https://ror.org/050rgn017"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320327235","display_name":"Servier","ror":"https://ror.org/034e7c066"},{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2160274347.pdf","grobid_xml":"https://content.openalex.org/works/W2160274347.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W43308025","https://openalex.org/W1968426988","https://openalex.org/W1977102586","https://openalex.org/W1984740259","https://openalex.org/W2012506661","https://openalex.org/W2042008548","https://openalex.org/W2057595002","https://openalex.org/W2057913111","https://openalex.org/W2058683641","https://openalex.org/W2058922633","https://openalex.org/W2071835038","https://openalex.org/W2077064143","https://openalex.org/W2096539888","https://openalex.org/W2103692362","https://openalex.org/W2113367996","https://openalex.org/W2128241213","https://openalex.org/W2131954113","https://openalex.org/W2137352234","https://openalex.org/W2139562487","https://openalex.org/W2149194615","https://openalex.org/W2160001758","https://openalex.org/W2165423692","https://openalex.org/W2170606300","https://openalex.org/W2408081177","https://openalex.org/W2486289350","https://openalex.org/W2509949587","https://openalex.org/W2596624061"],"related_works":["https://openalex.org/W2035920774","https://openalex.org/W2323757610","https://openalex.org/W2325915361","https://openalex.org/W2312203874","https://openalex.org/W2014784429","https://openalex.org/W1826263849","https://openalex.org/W2029089016","https://openalex.org/W2910094666","https://openalex.org/W1964234090","https://openalex.org/W2301357986"],"abstract_inverted_index":{"OBJECTIVE:":[0],"We":[1],"evaluated":[2],"the":[3,109,231,271],"addition":[4,66],"of":[5,67,140,145,198,259,273],"liraglutide":[6,46,73,262],"to":[7,62,70,148,179,191],"metformin":[8,39,71,260],"in":[9,270],"type":[10],"2":[11],"diabetes":[12],"followed":[13],"by":[14,158,212,218],"intensification":[15],"with":[16,56,164,200,221,249,261,275],"basal":[17],"insulin":[18,68,80,165,174,201,222,228,252,265],"(detemir)":[19],"if":[20],"glycated":[21],"hemoglobin":[22],"(A1C)":[23],"\u22657%.":[24],"RESEARCH":[25],"DESIGN":[26],"AND":[27],"METHODS:":[28],"In":[29,230],"988":[30,141],"participants":[31,107,199],"from":[32,121,133],"North":[33],"America":[34],"and":[35,45,181,238,244,250,263,282],"Europe":[36],"uncontrolled":[37],"on":[38],"\u00b1":[40],"sulfonylurea,":[41],"sulfonylurea":[42],"was":[43,98,267],"discontinued":[44],"1.8":[47],"mg/day":[48],"added":[49],"for":[50],"12":[51],"weeks":[52],"(run-in).":[53],"Subsequently,":[54],"those":[55],"A1C":[57,87,99,116,155,207],"\u22657%":[58],"were":[59,242],"randomized":[60,102,232],"1:1":[61],"26":[63],"weeks'":[64],"open-label":[65],"detemir":[69,81,166,175,202,223,253,266],"+":[72],"(n":[74,82,112,127,167,176],"=":[75,83,113,128,168,177],"162)":[76,169],"or":[77,224],"continuation":[78],"without":[79,173,205,227,251],"161).":[84],"Patients":[85],"achieving":[86],"<7%":[88,117],"continued":[89],"unchanged":[90],"treatment":[91,185],"(observational":[92],"arm).":[93],"The":[94],"primary":[95],"end":[96],"point":[97],"change":[100,119],"between":[101],"groups.":[103],"RESULTS:":[104],"Of":[105],"821":[106],"completing":[108],"run-in,":[110,138,216],"61%":[111],"498)":[114],"achieved":[115],"(mean":[118],"-1.3%":[120],"7.7%":[122],"at":[123,135,162],"start),":[124],"whereas":[125],"39%":[126],"323)":[129],"did":[130],"not":[131],"(-0.6%":[132],"8.3%":[134],"start).":[136],"During":[137],"167":[139],"(17%)":[142],"withdrew;":[143],"46%":[144],"these":[146],"due":[147],"gastrointestinal":[149],"adverse":[150],"events.":[151],"At":[152],"week":[153],"26,":[154],"decreased":[156,211],"further,":[157],"0.5%":[159],"(from":[160],"7.6%":[161],"randomization)":[163],"versus":[170,203],"0.02%":[171],"increase":[172],"157)":[178],"7.1":[180],"7.5%,":[182],"respectively":[183],"(estimated":[184],"difference":[186],"-0.52":[187],"[95%":[188],"CI":[189],"-0.68":[190],"-0.36];":[192],"P":[193],"<":[194],"0.0001).":[195],"Forty-three":[196],"percent":[197],"17%":[204],"reached":[206],"<7%.":[208],"Mean":[209],"weight":[210,280],"3.5":[213],"kg":[214,220,226],"during":[215],"then":[217,264],"0.16":[219],"0.95":[225],"detemir.":[229],"phase,":[233],"no":[234],"major":[235],"hypoglycemia":[236,240,285],"occurred":[237],"minor":[239],"rates":[241],"0.286":[243],"0.029":[245],"events":[246],"per":[247],"participant-year":[248],"(9.2":[254],"vs.":[255],"1.3%).":[256],"CONCLUSIONS:":[257],"Supplementation":[258],"well":[268],"tolerated":[269],"majority":[272],"patients,":[274],"good":[276],"glycemic":[277],"control,":[278],"sustained":[279],"loss,":[281],"very":[283],"low":[284],"rates.":[286]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2160274347","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":18},{"year":2015,"cited_by_count":26},{"year":2014,"cited_by_count":29},{"year":2013,"cited_by_count":32},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
